UPC CFI 619/2025

Vor dem UPC: GlaxoSmithKline Biologicals SA (20 Verfahren)·Moderna Group (20 Verfahren)

• 2026-08-10
  InfringementÖffentlich

  Zusammenfassung: The Hague Local Division disposed of revocation counterclaim UPC_CFI_2033/2025 under R. 360 RoP as devoid of purpose, EP4066856 having been finally revoked at the EPO, with GSK bearing Moderna's costs as the unsuccessful party. The decision on Moderna's stay request was postponed, the 2 October 2026 hearing cancelled, and the parties given the opportunity to brief the impact of the forthcoming written TBA decision on divisional EP4226941.

  Rechtsfragen anzeigen (4)

  • disposal of a counterclaim rendered devoid of purpose (R. 360 RoP)
  • stay of proceedings pending EPO opposition/appeal (R. 295 RoP)
  • effect of an EPO revocation on a parallel UPC action
  • relevance of a revoked parent to the validity of its divisional
• 2026-02-25
  Infringement ActionÖffentlich

  Zusammenfassung: The Hague Local Division addressed GSK's R.263 application to amend its claim and Moderna's R.9 application to dismiss late-filed submissions in a parallel mRNA vaccine infringement action.

  Rechtsfragen anzeigen (2)

  • Amendment of claim Rule 263 RoP
  • Late-filed submissions Rule 9 RoP
• 2025-11-28
  Infringement ActionÖffentlich

  Zusammenfassung: The Hague Local Division issued a procedural order under R. 302 RoP addressing a procedural step in proceedings before the court.

  Rechtsfragen anzeigen (1)

  • Procedural order (R. 302 RoP)